Cancer and COVID-19: Celebrate Safe Holidays This Season
Prasad R. Kudalkar, MD, medical oncologist and hematologist
November 23, 2020
As COVID screenings increase and positive results trend up, families are faced with difficult decisions about how to safely navigate the holiday season. Those with weakened immune systems, including many cancer patients, are more susceptible to... Read More
Treatment advancements and awareness are giving patients with pancreatic cancer hope
Evan Z. Lang, MD, MS, medical oncologist and hematologist who specializes in the treatment of pancreatic cancer
November 19, 2020
November is Pancreatic Cancer Awareness Month and the cancer experts at OHC believe the more you know about the disease – including risks, symptoms and early detection – as well as advancements in treatments, the better the chance for extended... Read More
Gifts allow breast cancer patients to focus on fun
D. Randolph Drosick, MD, a medical oncologist and hematologist at OHC who serves on the Karen Wellington Foundation Board of Directors
November 12, 2020
For women dealing with breast cancer their lives tend to be consumed by their disease and treatment. At OHC, our team leads patients through their cancer journey with advanced treatments as well as support services and resources to help them manage... Read More
New FDA-approved treatment for lung cancer is available at OHC
Benjamin T. Herms, MD, OHC medical oncologist and hematologist who specializes in lung and genitourinary cancer
November 10, 2020
OHC is excited to share that the US Food and Drug Administration has approved a new treatment for metastatic non-small cell lung cancer. This new treatment, which has been available at OHC since April through its clinical trials, offers these... Read More
Written by Rebecca Hendrixson and photographed by Robert White for Venue magazine. In the spring of 2017, during a routine checkup, Samantha England’s gynecologist found a lump in her left breast. A biopsy was performed, and results came back... Read More
OHC is evaluating a promising new treatment for metastatic HER2-positive breast cancer
Paula Weisenberger, MD, Medical Oncologist and Hematologist at OHC
October 29, 2020
One of every five breast cancers are HER2-positive breast cancers. This type tends to grow and spread faster than other breast cancers but are much more likely to respond to treatments that target the HER2 protein. A recent study reported that women... Read More
Three Things to Know Before You Cancel Your Mammogram
D. Randolph Drosick, MD, medical oncologist and hematologist who specializes in breast cancer
October 23, 2020
More than six months into the COVID-19 pandemic, fears are growing about the long-term impact on cancer rates. Put simply, Americans are skipping their screenings and the potential consequences are a major concern of OHC’s breast cancer experts.... Read More
OHC doctors are evaluating new treatment for women with advanced ovarian cancer.
Dené C. Wrenn, MD, MS, gynecologic oncologist with OHC
October 20, 2020
For many women diagnosed with ovarian cancer, their initial treatment, which typically includes chemotherapy, will stop the cancer’s growth. Unfortunately, many of these patients later experience a relapse. Even though the chemotherapy initially... Read More
OHC Exclusively Offers New Immunotherapy Treatment for Advanced Cervical Cancer
Ajit Gubbi, DO, Noted Gynecologic Oncologist
October 19, 2020
In the past 40 years, the number of cases of cervical cancer and the number of deaths from cervical cancer have decreased significantly. This encouraging trend is due in large part to early detection through Pap tests, the recent introduction of the... Read More
OHC is Helping Change the Lives of Patients with Breast Cancer through Clinical Trials
Patrick J. Ward, MD, PhD, Medical Oncologist, Hematologist and Co-Director of Research at OHC
October 12, 2020
Breast cancer is no longer the most common cancer for women in the United States. This is due to decades of efforts like Breast Cancer Awareness Month that have increased awareness of the benefits of breast cancer screenings and self-exams, which... Read More